3/20/23FROM THE INNOVATOR'S WORKBENCH WITH Casey McGlynn
Mark your calendar for an evening of storytelling with Casey McGlynn. A partner at Wilson Sonsini who formed the life sciences practice at the firm, McGlynn has formed, represented, sold, and taken public many of the most important medical device companies founded during the last 30 years. Register now!
Stanford Report, 11/9/22Stanford students and faculty create a mobile app to help understand and treat pain
Researchers struggled to gather quantitative and qualitative data to measure patients’ pain but a new mobile app, created by Stanford Biodesign students, will collect information that can help guide treatment.
Stanford Daily, 10/31/22REP. ANNA ESHOO TALKS HEALTHCARE INNOVATION AND HER CAREER DURING BYERS CENTER EVENT
US Representative Anna Eshoo, whose district includes Stanford, stressed the importance of policy and regulation in allowing for healthcare innovation during a recent conversation with Kavita Patel, a senior policy advisor at the Byers Center for Biodesign.
Pittsburgh Post-Gazette, 10/7/22TREATING MEDICAL DEVICES MORE LIKE PRESCRIPTION DRUGS WILL BE A BIG WIN FOR MEDICARE PATIENTS
In this editorial, Stanford Biodesign's director Josh Makower spotlights how, even after FDA approval, patients on Medicare routinely wait years for Centers for Medicare and Medicaid Services to determine whether to provide them with access to a clinically proven, effective new health technologies.
Biodesign Email Alerts
Sign-up to be notified of Biodesign news and events.
MedTech Intelligence 7/19/2022Increasing Diversity in MedTech
Founded in 2020 by Fogarty Innovations and the Stanford Byers Center for Biodesign, Diversity by Doing (DxD) is taking concrete action to increase diversity in the medtech industry. Ingrid Ellerbe, executive director of DxD, and Andrew Cleeland, CEO of Fogarty Innovation, talk about the mission of DxD and the resources it offers the industry.